Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,798
Companies 1,771
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,798 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 23 of 200 · By data quality, then INN

  1. levothyroxine sodium

    LEVOTHYROXINE SODIUM MAIA Biotechnology

    ORAL FDA: approved

  2. lidocaine

    LIGNOCAINE INJECTION (BRIDGEWEST) Lacuna Pharma Pty Ltd

    TOPICAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    N01BB20

  3. lidocaine hydrochloride

    LIDOCAINE HYDROCHLORIDE Regeneron Ireland Designated Activity Company (DAC)

    INTRADERMAL FDA: approved

  4. lifileucel

    AMTAGVI Iovance Biotherapeutics B.V.

    EMA: application withdrawn

    L01XL11

  5. linagliptin

    TRAJENTA Boehringer Ingelheim Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    A10BD11

  6. linezolid

    LINEZOLID Amneal Pharma Europe Ltd

    ORAL FDA: approved

  7. linvoseltamab

    LYNOZYFIC Regeneron UK Limited

    EMA: approved

    L01FX

  8. linvoseltamab-gcpt

    LYNOZYFIC Shanghai Antengene Corporation Limited

    INJECTION FDA: approved

  9. liothyronine sodium

    TRIOSTAT Teva Pharma GmbH

    INJECTION FDA: approved

  10. lipegfilgrastim

    LONQUEX Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    L03AA14

  11. liraglutide

    SAXENDA Teva Pharma GmbH

    SUBCUTANEOUS FDA: approved · EMA: approved · PMDA: approved · NMPA: clinical trials

    A10BJ02

  12. lisdexamfetamine dimesylate

    LISDEXAMFETAMINE DIMESYLATE ELITE PHARMACEUTICALS INC /NV/

    ORAL FDA: approved

  13. lisinopril

    APO-LISINOPRIL Alphapharm Pty Ltd

    ORAL FDA: approved · TGA: approved

  14. loncastuximab tesirine-lpyl

    ZYNLONTA ADC Therapeutics SA

    INJECTION FDA: approved

  15. loperamide hydrochloride

    LOPERAMIDE HYDROCHLORIDE Teva Pharma GmbH

    ORAL FDA: approved

  16. loratadine

    ALLEREZE Alphapharm Pty Ltd

    ORAL FDA: approved · TGA: approved

  17. lorazepam

    LORAZEPAM Amneal Pharma Europe Ltd

    INJECTION FDA: approved

  18. losartan potassium

    LOSARTAN POTASSIUM Teva Pharma GmbH

    ORAL FDA: approved

  19. loteprednol etabonate

    EYSUVIS Amneal Pharma Europe Ltd

    OPHTHALMIC FDA: approved

  20. lotilaner

    XDEMVY Tarsus Pharmaceuticals

    OPHTHALMIC FDA: approved

  21. lovastatin

    LOVASTATIN Teva Pharma GmbH

    ORAL FDA: approved

  22. loxapine hydrochloride

    LOXITANE C Teva Pharma GmbH

    INJECTION FDA: approved

  23. loxapine succinate

    LOXITANE ELITE PHARMACEUTICALS INC /NV/

    ORAL FDA: approved

  24. lubiprostone

    LUBIPROSTONE Amneal Pharma Europe Ltd

    ORAL FDA: approved · NMPA: clinical trials

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,798 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.